Top compounds associated with response to SMG9


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 7e-05
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.13 7e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 0.0003
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV